MedPath

Effects of Caffeine on Methacholine Challenge and Exhaled Nitric Oxide Levels.

Not Applicable
Completed
Conditions
Asthma
Registration Number
NCT01057875
Lead Sponsor
University of Saskatchewan
Brief Summary

To investigate whether or not the ingestion of caffeine with alter airway responsiveness to methacholine and/or change the level of exhaled nitric oxide.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • clinical diagnosis of asthma
  • FEV1 greater than 65%
Exclusion Criteria
  • asthma is poorly controlled
  • presence of other airway disease (e.g. COPD)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
methacholine pc201 hour post ingestion
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Saskatchewan

🇨🇦

Saskatoon, Saskatchewan, Canada

University of Saskatchewan
🇨🇦Saskatoon, Saskatchewan, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.